Europe is not only established as a location for pharmaceutical production but is also important for pharmaceutical research and development. Big plus points are the good infrastructure and the communication network, the proximity to the world’s leading German machinery and plant manufacturers, powerful clusters with other production companies,
But the globalized world is also forcing pharmaceutical companies to build new locations and collaborations in emerging markets where GBP INTERNATIONAL provides important assistance. For example, many non-OEM manufacturers of generic drugs are active in Asia.
